Pharmaceutical Services Negotiating Committee (PSNC) - News updates


New standards for the initial education and training of pharmacists introduced

The General Pharmaceutical Council have published new standards for the initial education and training of pharmacists. The implementation of these standards will transform the education and training of pharmacists, so they are able to play a much greater role in providing clinical care to patients and the public from their first day on the register,...

Discharge Medicines Service DoC now available

The Declaration of Competence (DoC) to support provision of the Discharge Medicines Service (DMS) is now available on the Centre for Pharmacy Postgraduate Education (CPPE) website. The DMS will be an Essential service within the NHS Community Pharmacy Contractual Framework from 15th February 2021. This DoC must be completed by all pharmacists and pharmacy technicians...

Pharmacy Advice Audit 2021: Paperwork and guidance now available

Community pharmacy contractors can now access guidance about the upcoming PSNC Pharmacy Advice Audit for 2021, including full details of how to take part. As announced last week, pharmacy teams are being encouraged to take part in an audit that will capture information about the reasons why people choose to visit community pharmacies. PSNC is increasingly...

PSNC Pharmacy Advice Audit 2021 – Team Briefing Sheet

This briefing describes how community pharmacy teams can take part in PSNC’s audit to capture information about the reasons why people choose to visit community pharmacies. PSNC Briefing 001/21: PSNC Pharmacy Advice Audit 2021 – Team Briefing Sheet Related document: Audit Template If you have any queries on this PSNC Briefing or you require more...

Indemnity arrangements for the COVID-19 vaccination programme – update

Yesterday, Nadhim Zahawi, Minister for COVID Vaccination Deployment made a statement on the provision of indemnity for the vaccination programme, including provision by community pharmacy in England. The Minister’s statement provides clarity on why the indemnity has been provided to community pharmacy and also extends the scheme to 30th June 2021. He stated: “Without adequate...

MHRA Company Led Drug Alert and Recall: Instanyl 100mcg nasal spray solution

CLDA number: CLDA (21)A/01 Date issued: 18th January 2021 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for: Instanyl 100mcg nasal spray solution Product Batch number Expiry Date Pack Size First Distributed Instanyl 100mcg Nasal Spray 447055 31/10/2021 1 x 6 single dose containers 14/04/2020 Takeda UK Limited is...

PSNC Video Message from CEO Simon Dukes

PSNC Chief Executive Simon Dukes has recorded a new video message for community pharmacy contractors and their teams. In the video Simon reflects on the extraordinary year just passed and looks to the challenges ahead, noting in particular the stoicism and commitment of community pharmacy teams and calling for an end to the slow responses...

January 2021 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack Size Price Concession Ciprofloxacin 500mg tablets 10 £3.85 Duloxetine 20mg gastro-resistant capsules 28 £8.68 Duloxetine 30mg gastro-resistant capsules 28 £2.39 Duloxetine 60mg gastro-resistant capsules 28 £3.99 Enalapril 10mg tablets 28 £6.10 Enalapril 20mg tablets 28...

Discharge Medicines Service Toolkit published

NHS England and NHS Improvement (NHSE&I) have today (15th January 2021), published the NHS Discharge Medicines Service (DMS) Toolkit for Pharmacy Staff in Community, Primary and Secondary Care. The toolkit aims to assist and support cross sector implementation of the DMS as an Essential service in all NHS community pharmacies in England. It sets out...

Medicine Supply Notification: Sancuso (granisetron) 3.1mg/24 hours transdermal patches

Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Sancuso (granisetron) 3.1mg/24 hours transdermal patches Sancuso® (granisetron) 3.1mg/24 hours transdermal patches are out of stock until mid-February 2021 (other formulations of granisetron (tablets and injection) are not affected). Specialist importer companies have indicated that unlicensed imports of granisetron 3.1mg/24hours...